Literature DB >> 12387900

The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge.

Rakel López de Maturana1, Dan Donnelly.   

Abstract

The mutation of Asp198 to Asn in the receptor for glucagon-like peptide-1(7-36)amide (GLP-1) had no effect upon GLP-1 affinity whereas substitution with Ala greatly reduced affinity, demonstrating the importance of polarity rather than negative charge at Asp198. However, the Asp198-Ala mutation had less effect upon the affinity of Exendin-4, a peptide agonist that has been shown previously not to require its N-terminus for high affinity. Moreover, the affinity of a truncated GLP-1 analogue lacking the first eight residues was not affected by the Asp198-Ala mutation, demonstrating that Asp198 is required for maintaining the binding site of the N-terminal region of GLP-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12387900     DOI: 10.1016/s0014-5793(02)03492-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation.

Authors:  Cassandra Koole; Denise Wootten; John Simms; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

Review 2.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.

Authors:  R J Mann; N E Nasr; J K Sinfield; E Paci; D Donnelly
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.

Authors:  Suleiman Al-Sabah; Dan Donnelly
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

Review 5.  Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.

Authors:  M Dong; C Koole; D Wootten; P M Sexton; L J Miller
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 6.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

7.  Ligand binding pocket formed by evolutionarily conserved residues in the glucagon-like peptide-1 (GLP-1) receptor core domain.

Authors:  Mi Jin Moon; Yoo-Na Lee; Sumi Park; Arfaxad Reyes-Alcaraz; Jong-Ik Hwang; Robert Peter Millar; Han Choe; Jae Young Seong
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

8.  Acylation of exenatide by glycolic acid and its anti-diabetic activities in db/db mice.

Authors:  Rongcai Liang; Xiang Li; Renyu Zhang; Yanan Shi; Aiping Wang; Daquan Chen; Kaoxiang Sun; Wanhui Liu; Youxin Li
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

9.  Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats.

Authors:  Jason G Barrera; David A D'Alessio; Daniel J Drucker; Stephen C Woods; Randy J Seeley
Journal:  Diabetes       Date:  2009-09-09       Impact factor: 9.461

10.  Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor.

Authors:  Christina Rye Underwood; Patrick Garibay; Lotte Bjerre Knudsen; Sven Hastrup; Günther H Peters; Rainer Rudolph; Steffen Reedtz-Runge
Journal:  J Biol Chem       Date:  2009-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.